fda approved indications for semaglutide has a new, higher-dose 7.2 mg weekly injection of #Wegovy (# semaglutide) long-term weight management in adults with obesity or overweight. 🔹Indication: It is intended as a “step-up” therapy for FDA Approves Semaglutide to Reduce

Generic liraglutide: Sometimes covered for type 2 diabetes, rarely for weight loss

If you have obesity-related conditionssuch as type 2 diabetes, hypertension, or sleep apneastarting now with an approved injectable GLP-1 may make sense

She adds that some people "have significant depression with those shots," noting that some patients lose weight as fast as those who undergo bariatric surgery, which can also result in increased depression, anxiety, and suicidal ideation in patients

10.1074/mcp.T600050-MCP200 76 ShinN.-Y.LiuQ.StamerS

The reported distribution of causes of death for this cohort included: CVD (36%) Cancer (32%) Natural Causes (25%) Other/suicide/accidents (6%) 4 While the authors didnt investigate the association between cause of death and POP chemicals, there is substantial human and animal evidence linking POP exposure to mortality from both cardiovascular disease (CVD) and cancer, which were the two most common causes of death in this study.29,30 Moreover, the study population was derived from Finland, a country with several known POP toxicity risk hotspots